Original Research
Original Research
Predictors of the Persistence and Emergence of ADHD Over a 9-Year Period
May 7, 2019
What factors may predict the onset of ADHD in adolescence? This population-based study used baseline and follow-up phone interviews to identify predictors and evaluate the validity of subthreshold and...
Original Research
Worsening of Suicidal Ideation During AD Treatment
May 7, 2019
Antidepressants are effective in preventing suicide, but some antidepressant-treated patients experience increased suicidal ideation. Read this article to learn if clinical features and biomarkers can predict worsened suicidal ideation...
Original Research
Effectiveness of 3 Suicide Prevention Programs
February 26, 2019
Most evidence concerning suicide prevention strategies comes from either non-experimental epidemiologic designs or randomized controlled trials, but there is a growing call for data from actual clinical practice. Learn...
Original Research
CAN-BIND-1 Outcomes and Early Response Prediction in MDD
February 5, 2019
Antidepressant medications are often prescribed with little certainty about their potential effectiveness in individual patients. Can early symptom reduction help predict later symptomatic and functional outcomes of antidepressant treatment?...
Original Research
Psychotic Features in Patients With MDD
January 15, 2019
Psychotic features within major depressive disorder (MDD) are associated with poor treatment outcome. This article explores whether sociodemographic and clinical characteristics of and pharmacologic treatments received by patients with...
Original Research
Long-Term Remission With Cariprazine in Patients With Schizophrenia
January 8, 2019
When treating patients with schizophrenia, achieving stable, long-term remission is an important step toward the goal of functional recovery. This study evaluated the effect of cariprazine on several measures...
Original Research
Cost-Effectiveness of "Next-Step" Depression Treatment Strategies
December 18, 2018
Aripiprazole is commonly prescribed as a next-step pharmacotherapy for treatment-resistant depression, but its cost-effectiveness as an adjunct to antidepressants is unknown. Read this article to learn how the cost-effectiveness...
Original Research
Valbenazine for Tardive Dyskinesia: Results From the KINECT 3 Study
December 18, 2018
Could valbenazine help your patients who experience antipsychotic-induced abnormal movements? This follow-up analysis of a phase 3 study provides further insights into the efficacy of valbenazine for tardive dyskinesia...
